Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Cannabigerol

PhytochemicalCannabinoidBest with a meal

Useful mainly for no use is clinically established; interest is exploratory.

Quick decision guide

May help most

no use is clinically established; interest is exploratory

Common dosing range

25–200 mg/day (not standardized)

When to expect effects

Sublingual 15–30 minutes; capsules 1–2 hours (for any subjective effect)

Watch out for

human evidence is essentially absent; product quality and labeling are inconsistent

What is it

Cannabigerol (CBG) is a non-intoxicating cannabinoid found in the cannabis plant (Cannabis sativa). It is often called the 'mother cannabinoid' because its acid form (CBGA) is the precursor from which THC, CBD, and CBC are biosynthesized in the plant. CBG is typically present in low amounts in mature plants and is increasingly extracted or isolated for use in dietary supplements.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

you accept it is experimental with no proven clinical benefit
you use only third-party-tested products and have checked local legality
you are not pregnant, not on interacting medications, and tolerate it

Probably skip if…

you want a treatment backed by human trials for any condition
you take CYP-metabolized medications and cannot consult a clinician
you need predictable dosing and verified label accuracy

Evidence at a glance

anxiety and mood

Limited Evidence
Effect
Not established in humans
Best fit
not established
Time
Unknown

inflammation and pain

Mixed Evidence
Effect
Not established in humans
Best fit
not established
Time
Unknown

antibacterial activity

Mixed Evidence
Effect
Not established in humans
Best fit
not established (laboratory research only)
Time
Unknown

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

anxiety and mood

Supplement benefit
Limited Evidence

Its 5-HT1A and adrenergic activity and possible anandamide reuptake inhibition provide a plausible mechanism for mood and anxiety effects, and some user surveys report perceived benefit. Controlled human evidence is absent, so these reports cannot be treated as proof of effect.

Effect size
Not established in humans
Time to effect
Unknown
Best fit
not established

Bottom line: Mood and anxiety effects rest on mechanism and self-report, not clinical trials.

SourceCuttler et al., 2024 — PMC

inflammation and pain

Mechanism only
Mixed Evidence

CBG acts on alpha-2 adrenergic, 5-HT1A, TRP, and PPAR-gamma targets and shows anti-inflammatory and analgesic effects in cell and animal models. There are no adequate human trials, so any benefit for pain or inflammation in people is unproven.

Effect size
Not established in humans
Time to effect
Unknown
Best fit
not established

Bottom line: Anti-inflammatory effects are preclinical only; do not expect proven pain relief.

SourceJeon et al., 2025 — PubMed

antibacterial activity

Mechanism only
Mixed Evidence

CBG shows antibacterial activity in vitro, including against methicillin-resistant Staphylococcus aureus (MRSA). This is laboratory research with no human studies, and it does not support using CBG to treat infections.

Effect size
Not established in humans
Time to effect
Unknown
Best fit
not established (laboratory research only)

Bottom line: Antibacterial effects are confined to the lab and have no clinical application yet.

SourceWu et al., 2025 — PubMedMandal et al., 2026 — PMC

How it works

CBG interacts with the endocannabinoid system but with a different binding profile from THC or CBD. It has low affinity for CB1 and CB2 cannabinoid receptors and instead acts primarily on other targets: it is a partial alpha-2 adrenergic receptor agonist, a 5-HT1A receptor antagonist, and may inhibit the reuptake of anandamide (an endogenous cannabinoid). It also affects TRP channels involved in sensory and pain signaling and PPAR-gamma. These multiple targets account for the wide range of preclinical effects observed: anti-inflammatory, neuroprotective, antibacterial (notably against MRSA in lab studies), appetite-stimulating, and potential anticancer effects in animal and cell models. Human clinical evidence is limited; most current use is based on user reports and preclinical research. CBG is fat-soluble; bioavailability is variable and improved by lipid co-administration.

How to take it

1. Typical dose
typically 10–50 mg per dose, 25–200 mg/day
2. Timing
any time of day; effects vary from alerting to relaxing between users
3. With food
with food, ideally containing fat, to improve absorption
4. How long to try
no established trial duration; long-term safety data are lacking

What to track

subjective effect
dry mouth or drowsiness
appetite changes
any interaction with concurrent medications

3 commercial forms

Compare the main delivery options and what they’re best suited for.

CBG isolate

Crystalline isolate used in supplements, often with carrier oils. THC-free.

Pure CBG; variable absorption depending on delivery form.

CBG distillate

Concentrated oil form used in tinctures and capsules.

Refined extract with high CBG content and minor cannabinoids.

Full or broad spectrum hemp extract with CBG

Contains CBG alongside CBD and other cannabinoids; may have differential effects.

Provides multiple cannabinoids for potential entourage effect.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

dry mouthdrowsiness or alertness (variable)appetite changesmild GI symptoms

Who should avoid it

  • pregnant or breastfeeding women
  • children except under specialist guidance
  • people on CYP-metabolized medications without clinician input

Pregnancy & breastfeeding

Avoid in pregnancy and breastfeeding due to limited safety data and effects on the endocannabinoid system.

Interactions

CYP3A4/CYP2D6/CYP1A2-metabolized drugsModerate

CBG may inhibit these enzymes and raise drug levels

CNS depressantsModerate

may enhance sedation

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for…

third-party certificate of analysis
stated CBG content per serving
verified THC content within legal limits

Be skeptical of…

the mother cannabinoid heals everything
proven anti-cancer
kills antibiotic-resistant infections
clinically proven anti-inflammatory

Frequently asked questions

Will CBG get me high?⌄

No. CBG is non-intoxicating because it has low affinity for the CB1 receptor that mediates THC's psychoactive effects.

Is CBG legal?⌄

In the US, hemp-derived CBG (with less than 0.3 percent THC) is federally legal but state laws vary. Other countries have their own rules. Check local regulations.

How is CBG different from CBD?⌄

Both are non-intoxicating cannabinoids. CBG has different receptor targets and may have stronger antibacterial and appetite-stimulating effects. Research on CBG is much less developed than on CBD.

References by claim

inflammation and pain

Jeon et al., 2025 — PubMed (2025) link

anxiety and mood

Cuttler et al., 2024 — PMC (2024) link

antibacterial activity

Wu et al., 2025 — PubMed (2025) link

Mandal et al., 2026 — PMC (2026) link

Track Cannabigerol with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.